June 19, 2020 / 12:19 PM / 23 days ago

BRIEF-Ampio To Start First Clinical Trial In COVID-19 Program

June 19 (Reuters) - Ampio Pharmaceuticals Inc:

* AMPIO TO START FIRST CLINICAL TRIAL IN COVID-19 PROGRAM

* AMPIO PHARMACEUTICALS - WILL BEGIN PHASE 1 CLINICAL TRIAL TO EVALUATE IV AMPION AS A TREATMENT FOR COVID-19 PATIENTS ON SUPPLEMENTAL OXYGEN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below